Last 7 days
1.4%
Last 30 days
-5.1%
Last 90 days
-9.2%
Trailing 12 Months
3.3%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 3.8B | 3.9B | 4.0B | 0 |
2022 | 3.8B | 3.8B | 3.8B | 3.8B |
2021 | 3.5B | 3.6B | 3.7B | 3.8B |
2020 | 0 | 0 | 0 | 3.4B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Sep 29, 2023 | de schutter richard u | acquired | 26,865 | 16.95 | 1,585 | - |
Sep 29, 2023 | paulson john | acquired | 21,865 | 16.95 | 1,290 | - |
Sep 29, 2023 | robertson russel c | acquired | 25,611 | 16.95 | 1,511 | - |
Sep 29, 2023 | bernier nathalie d. | acquired | 24,984 | 16.95 | 1,474 | - |
Jul 25, 2023 | munsch frederick | sold (taxes) | -26,023 | 19.82 | -1,313 | svp, controller and cao |
Jul 25, 2023 | eldessouky sam | sold (taxes) | -83,600 | 19.82 | -4,218 | evp and cfo |
Jul 25, 2023 | hashad yehia | sold (taxes) | -79,200 | 19.82 | -3,996 | evp of r&d and cmo |
Jul 25, 2023 | bonnefoy luc | sold (taxes) | -44,396 | 19.82 | -2,240 | president, surgical |
Jun 30, 2023 | bernier nathalie d. | acquired | 24,987 | 20.07 | 1,245 | - |
Jun 30, 2023 | robertson russel c | acquired | 25,609 | 20.07 | 1,276 | - |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 06, 2023 | CITIGROUP INC | reduced | -95.56 | -588,904 | 23,165 | -% |
Nov 29, 2023 | Alamar Capital Management, LLC | sold off | -100 | -2,192,350 | - | -% |
Nov 15, 2023 | MORGAN STANLEY | reduced | -46.5 | -1,144,980 | 943,741 | -% |
Nov 15, 2023 | JANE STREET GROUP, LLC | added | 64.08 | 130,539 | 468,939 | -% |
Nov 14, 2023 | Quadrature Capital Ltd | new | - | 465,637 | 465,637 | 0.01% |
Nov 14, 2023 | Alberta Investment Management Corp | added | 39.1 | 3,409,000 | 22,912,900 | 0.24% |
Nov 14, 2023 | ArrowMark Colorado Holdings LLC | sold off | -100 | -4,714,460 | - | -% |
Nov 14, 2023 | CASPIAN CAPITAL LP | unchanged | - | -1,039,350 | 5,646,450 | 13.98% |
Nov 14, 2023 | Covalent Partners LLC | unchanged | - | -38,064 | 206,790 | 0.66% |
Nov 14, 2023 | MANGROVE PARTNERS | sold off | -100 | -19,415,700 | - | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | bausch health companies inc. | 88.7% | 310,449,643 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Nov 13, 2023 | 8-K/A | Current Report | |
Nov 07, 2023 | 8-K/A | Current Report | |
Nov 01, 2023 | 8-K | Current Report | |
Nov 01, 2023 | 10-Q | Quarterly Report | |
Oct 03, 2023 | 4 | Insider Trading | |
Oct 03, 2023 | 4 | Insider Trading | |
Oct 03, 2023 | 4 | Insider Trading | |
Oct 03, 2023 | 4 | Insider Trading | |
Sep 29, 2023 | 8-K | Current Report | |
Sep 14, 2023 | 8-K | Current Report |
Income Statement (Quarterly) | (In Millions) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Revenue | -2.7% | 1,007 | 1,035 | 931 | 996 | 942 | 941 | 889 | 1,001 | 949 | 934 | 881 | - |
Costs and Expenses | -2.5% | 967 | 992 | 933 | 945 | 896 | 885 | 835 | 909 | 855 | 876 | 796 | - |
S&GA Expenses | 0.2% | 418 | 417 | 418 | 386 | 381 | 368 | 343 | 365 | 348 | 358 | 318 | - |
Interest Expenses | 31.0% | 76.00 | 58.00 | 50.00 | 47.00 | 35.00 | 44.00 | 20.00 | - | - | - | - | - |
Income Taxes | 350.0% | 45.00 | 10.00 | 33.00 | -2.00 | 34.00 | 20.00 | 6.00 | 32.00 | 25.00 | 21.00 | 47.00 | - |
Earnings Before Taxes | -84.2% | -35.00 | -19.00 | -55.00 | -2.00 | 19.00 | 27.00 | 29.00 | 86.00 | 88.00 | 67.00 | 77.00 | - |
Net Income | -162.5% | -84.00 | -32.00 | -90.00 | -1.00 | -18.00 | 5.00 | 20.00 | 51.00 | 60.00 | 44.00 | 27.00 | - |
Balance Sheet | (In Millions) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 15.5% | 13,068 | 11,315 | 11,169 | 11,144 | 10,696 | 11,002 | 10,907 | 10,823 |
Current Assets | 6.4% | 2,464 | 2,315 | 2,184 | 2,137 | 1,859 | 2,001 | 1,719 | 1,635 |
Cash Equivalents | -6.2% | 360 | 384 | 346 | 354 | 287 | 446 | 190 | 177 |
Inventory | 7.9% | 754 | 699 | 697 | 628 | 605 | 606 | 598 | 572 |
Net PPE | -0.8% | 1,284 | 1,294 | 1,296 | 1,300 | 1,222 | 1,243 | 1,225 | 1,225 |
Goodwill | -0.3% | 4,526 | 4,540 | 4,522 | 4,507 | 4,415 | 4,493 | 4,553 | 4,586 |
Liabilities | 44.3% | 6,185 | 4,285 | 4,117 | 4,043 | 3,901 | 4,031 | 3,691 | 1,421 |
Current Liabilities | 4.6% | 1,386 | 1,325 | 1,254 | 1,296 | 1,199 | 1,273 | 1,092 | 1,099 |
LT Debt, Current | 20.0% | 30.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | - | - |
LT Debt, Non Current | 70.3% | 4,435 | 2,604 | 2,508 | 2,411 | 2,413 | 2,417 | - | - |
Shareholder's Equity | -1.1% | 6,883 | 6,958 | 7,052 | 7,033 | 6,729 | 6,971 | 7,216 | 9,402 |
Retained Earnings | -72.4% | -200 | -116 | -84.00 | 6.00 | 7.00 | 25.00 | 20.00 | - |
Additional Paid-In Capital | 0.2% | 8,334 | 8,321 | 8,305 | 8,285 | 8,108 | 8,088 | 8,219 | - |
Shares Outstanding | 0.1% | 351 | 351 | 350 | 350 | 350 | 350 | 350 | 350 |
Minority Interest | -8.3% | 66.00 | 72.00 | 69.00 | 68.00 | 66.00 | 75.00 | 76.00 | 73.00 |
Cashflow (Quarterly) | (In Thousands) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Cashflow From Operations | 300.0% | 48,000 | -24,000 | -56,000 | 159,000 | 27,000 | 156,000 | 3,000 | 162,000 | 273,000 | 250,000 | 188,000 | - |
Share Based Compensation | -11.1% | 16,000 | 18,000 | 24,000 | 17,000 | 18,000 | 11,000 | 16,000 | 17,000 | 16,000 | 15,000 | 14,000 | - |
Cashflow From Investing | -6621.4% | -1,882,000 | -28,000 | -64,000 | -90,000 | -49,000 | -35,000 | -41,000 | -81,000 | -40,000 | -45,000 | -48,000 | - |
Cashflow From Financing | 1912.2% | 1,811,000 | 90,000 | 91,000 | -7,000 | -109,000 | 145,000 | 52,000 | -37,000 | -378,000 | -183,000 | -114,000 | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenues | ||||
Total revenues | $ 1,007 | $ 942 | $ 2,973 | $ 2,772 |
Expenses | ||||
Selling, general and administrative (Note 4) | 418 | 381 | 1,253 | 1,092 |
Research and development (Note 4) | 82 | 77 | 244 | 229 |
Amortization of intangible assets | 47 | 59 | 160 | 188 |
Other expense, net | 28 | 7 | 54 | 8 |
Total expenses | 967 | 896 | 2,892 | 2,616 |
Operating income | 40 | 46 | 81 | 156 |
Interest income | 4 | 2 | 12 | 3 |
Interest expense (Note 4) | (76) | (35) | (184) | (99) |
Foreign exchange and other | (3) | 6 | (18) | 15 |
(Loss) income before provision for income taxes | (35) | 19 | (109) | 75 |
Provision for income taxes | (45) | (34) | (88) | (60) |
Net (loss) income | (80) | (15) | (197) | 15 |
Net income attributable to noncontrolling interest | (4) | (3) | (9) | (8) |
Net (loss) income attributable to Bausch + Lomb Corporation | $ (84) | $ (18) | $ (206) | $ 7 |
Basic (loss) income per share attributable to Bausch + Lomb Corporation (in usd per share) | $ (0.24) | $ (0.05) | $ (0.59) | $ 0.02 |
Diluted (loss) income per share attributable to Bausch + Lomb Corporation (in usd per share) | $ (0.24) | $ (0.05) | $ (0.59) | $ 0.02 |
Basic weighted-average common shares (in shares) | 350.8 | 350.0 | 350.4 | 350.0 |
Diluted weighted-average common shares (in shares) | 350.8 | 350.0 | 350.4 | 350.1 |
Product sales | ||||
Revenues | ||||
Total revenues | $ 1,004 | $ 937 | $ 2,963 | $ 2,755 |
Expenses | ||||
Cost of goods sold (excluding amortization and impairments of intangible assets) (Note 4) and Cost of other revenues | 391 | 370 | 1,179 | 1,093 |
Other revenues | ||||
Revenues | ||||
Total revenues | 3 | 5 | 10 | 17 |
Expenses | ||||
Cost of goods sold (excluding amortization and impairments of intangible assets) (Note 4) and Cost of other revenues | $ 1 | $ 2 | $ 2 | $ 6 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 355 | $ 354 |
Restricted cash | 5 | 26 |
Trade receivables, net (Note 4) | 783 | 724 |
Inventories, net | 754 | 628 |
Prepaid expenses and other current assets (Note 4) | 567 | 405 |
Total current assets | 2,464 | 2,137 |
Property, plant and equipment, net | 1,284 | 1,300 |
Intangible assets, net | 3,662 | 2,058 |
Goodwill | 4,526 | 4,507 |
Deferred tax assets, net | 920 | 927 |
Other non-current assets (Note 4) | 212 | 215 |
Total assets | 13,068 | 11,144 |
Current liabilities: | ||
Accounts payable (Note 4) | 364 | 370 |
Accrued and other current liabilities | 992 | 901 |
Current portion of long-term debt | 30 | 25 |
Total current liabilities | 1,386 | 1,296 |
Deferred tax liabilities, net | 11 | 7 |
Other non-current liabilities | 353 | 329 |
Long-term debt | 4,435 | 2,411 |
Total liabilities | 6,185 | 4,043 |
Commitments and contingencies (Note 17) | ||
Equity | ||
Common shares, no par value, unlimited shares authorized, 350,824,535 and 350,000,749 issued and outstanding at September 30, 2023 and December 31, 2022, respectively | 0 | 0 |
Additional paid-in capital | 8,334 | 8,285 |
Accumulated (deficit) earnings | (200) | 6 |
Accumulated other comprehensive loss | (1,317) | (1,258) |
Total Bausch + Lomb Corporation shareholders’ equity | 6,817 | 7,033 |
Noncontrolling interest | 66 | 68 |
Total equity | 6,883 | 7,101 |
Total liabilities and equity | $ 13,068 | $ 11,144 |
CEO | Mr. Brenton L. Saunders J.D. |
---|---|
WEBSITE | www.bausch.com |
EMPLOYEES | 13000 |